Evidence map›Paper›PMID 26735576›Full record

ArticleOncotarget2016

Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcome.

Alessio Naccarati, Fabio Rosa, Veronika Vymetalkova, Elisa Barone, Katerina Jiraskova, Cornelia Di Gaetano, Jan Novotny, Miroslav Levy, Ludmila Vodickova, Federica Gemignani and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review.International journal of molecular sciences · 2018
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Frontiers in molecular biosciences · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Alessio NaccaratiMolecular and Genetic Epidemiology Research Unit, Human Genetics Foundation, Turin, Italy.
Fabio RosaGenomic Variation in Human Populations and Complex Diseases Research Unit, Human Genetics Foundation, Turin, Italy.
Veronika VymetalkovaDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine, Prague, Czech Republic.
Elisa BaroneDepartment of Biology, University of Pisa, Pisa, Italy.
Katerina JiraskovaDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine, Prague, Czech Republic.
Cornelia Di GaetanoGenomic Variation in Human Populations and Complex Diseases Research Unit, Human Genetics Foundation, Turin, Italy.
Jan NovotnyDepartment of Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Miroslav LevyDepartment of Surgery, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic.
Ludmila VodickovaDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine, Prague, Czech Republic.
Federica GemignaniDepartment of Biology, University of Pisa, Pisa, Italy.
Tomas BuchlerDepartment of Oncology, Thomayer Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Stefano LandiDepartment of Biology, University of Pisa, Pisa, Italy.
Pavel VodickaDepartment of Molecular Biology of Cancer, Institute of Experimental Medicine, Prague, Czech Republic.
Barbara PardiniGenomic Variation in Human Populations and Complex Diseases Research Unit, Human Genetics Foundation, Turin, Italy.
Charles University · CZCzech Academy of Sciences, Institute of Experimental Medicine · CZItalian institute for Genomic Medicine · ITUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic variations in 3' untranslated regions of target genes may affect microRNA binding, resulting in differential protein expression. microRNAs regulate DNA repair, and single-nucleotide polymorphisms in miRNA binding sites (miRSNPs) may account for interindividual differences in the DNA repair capacity. Our hypothesis is that miRSNPs in relevant DNA repair genes may ultimately affect cancer susceptibility and impact prognosis.In the present study, we analysed the association of polymorphisms in predicted microRNA target sites of double-strand breaks (DSBs) repair genes with colorectal cancer (CRC) risk and clinical outcome. Twenty-one miRSNPs in non-homologous end-joining and homologous recombination pathways were assessed in 1111 cases and 1469 controls. The variant CC genotype of rs2155209 in MRE11A was strongly associated with decreased cancer risk when compared with the other genotypes (OR 0.54, 95% CI 0.38-0.76, p = 0.0004). A reduced expression of the reporter gene was observed for the C allele of this polymorphism by in vitro assay, suggesting a more efficient interaction with potentially binding miRNAs. In colon cancer patients, the rs2155209 CC genotype was associated with shorter survival while the TT genotype of RAD52 rs11226 with longer survival when both compared with their respective more frequent genotypes (HR 1.63, 95% CI 1.06-2.51, p = 0.03 HR 0.60, 95% CI 0.41-0.89, p = 0.01, respectively).miRSNPs in DSB repair genes involved in the maintenance of genomic stability may have a role on CRC susceptibility and clinical outcome.

Indexed as

Polymorphism, Single Nucleotide3' Untranslated RegionsAdultAgedAged, 80 and overBinding SitesBiomarkers, TumorCase-Control StudiesColorectal NeoplasmsDNA RepairFemaleFollow-Up StudiesGenetic Predisposition to DiseaseGenotypeHumansMale3' Untranslated RegionsBiomarkers, TumorMicroRNAsMRE11 Homologue ProteinMRE11 protein, humanRad52 DNA Repair and Recombination ProteinRAD52 protein, human3′UTR polymorphismscolorectal cancer risk and clinical outcomesdouble-strand break repair (DSBR) genesmiRNA binding sitesMRE11A

Identifiers

PMID26735576
PMCPMC5029617
OpenAlexW2344143064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.